Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir.
| Publicado en: | Clinical Infectious Diseases Vol. 72; no. 10; pp. 1823 - 1826 |
|---|---|
| Autor principal: | |
| Formato: | commentary editorial tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
5/15/2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150407125&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 150407125 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10584838 46X jtl: Clinical Infectious Diseases issn: 10584838 maglogo: N pubinfo: dt: 5/15/2021 vid: 72 iid: 10 pid: 622 pub: Oxford University Press / USA artinfo: ui: 150407125 150407125 150407125 10.1093/cid/ciaa982 150407125 ppf: 1823 ppct: 3 formats: tig: atl: Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir. aug: au: Morse, Gene D affil: University at Buffalo , Buffalo, New York , USA sug: subj: Drug Interactions Implementation Science Research Methodology Efavirenz Pharmacokinetics Drug Resistance pubtype: Academic Journal doctype: commentary editorial tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|